Table 1 |
||||||
|
Clinical features of patients with juvenile idiopathic arthritis |
||||||
| Subclass |
n |
Female/male |
Age in years (median [range]) |
Disease duration in months (median [range]) |
B27+ (n) |
ANA+ (n) |
|
|
||||||
| Oligoarthritis |
13 |
8/5 |
8 (2–17) |
34 (6–106) |
1 |
6 |
| Ext. oligoarthritis |
2 |
2/0 |
12 (10–14) |
98 (65–131) |
0 |
1 |
| Systemic arthritis |
1 |
0/1 |
15 |
156 |
0 |
0 |
| Psoriatic |
8 |
4/4 |
13 (6–15) |
42 (5–175) |
2 |
6 |
| ERA |
7 |
1/6 |
13 (9–14) |
12 (1–60) |
3 |
2 |
| Polyarthritis RF- |
5 |
1/4 |
10 (5–14) |
10 (4–129) |
1 |
3 |
| Polyarthritis RF+ |
1 |
1/0 |
15 |
12 |
0 |
0 |
| Other |
2 |
0/2 |
11 (9–13) |
3 (3–3) |
0 |
0 |
| Total |
39 |
17/22 |
11 (2–17) |
27 (1–175) |
7 |
18 |
|
|
||||||
|
ANA, antinuclear antibody; RF, rheumatoid factor; |
||||||
|
Black et al. Arthritis Res Ther 2003 5:R277 doi:10.1186/ar791 |
||||||
